Bupivacaine Hci Injection, Solution
Product Images NDC 51662-1581

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hci (NDC 51662-1581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

A text panel warning about the 0.75% concentration of Bupivacaine Hydrochloride. It states that this concentration is not recommended for obstetrical anesthesia due to reports of cardiac arrest and difficult resuscitation, particularly associated with epidural use in obstetrical patients. It advises reserving the 0.75% concentration for surgical procedures requiring significant muscle relaxation and prolonged effect.*

FDA Label Image

Case Labeling (Case U)

Label for BUPIVACAINE HCI Injection USP 0.25% (2.5 mg/mL) in a 50 mL vial, supplied as a case of 25 vials. The label specifies 125 mg per 50 mL dose, with storage instructions and formulation details. Manufactured by HF Acquisition Co. LLC, Mukilteo, WA, with NDC 51662-1581-3.*

FDA Label Image

Dosage (Dosage)

A table titled 'Recommended Concentrations and Doses of Bupivacaine Hydrochloride Injection' presenting types of nerve blocks, corresponding concentration percentages, dose volumes (mL), dose amounts (mg), and descriptions of motor block effects. The types include local infiltration, epidural (various concentrations), caudal, peripheral nerves, retrobulbar, sympathetic, and epidural test dose with epinephrine. Doses range up to specific maximum values with motor block effects varying from partial to complete.*

FDA Label Image

Pouch (Pouch U)

Label for Bupivacaine HCl Injection, USP 0.25% (2.5 mg/mL) in a 50 mL vial. The label states 125 mg per 50 mL and indicates use for infiltration and nerve block. It includes manufacturer HF Acquisition Co., LLC, Mukilteo, WA. The label shows NDC 51662-1581-2, lot number 123456, and expiration date 2030-01-01, with storage instructions and formulation details.*

FDA Label Image

Precautions (Precautions)

A table titled 'Examples of Drugs Associated with Methemoglobinemia,' listing drug classes in the left column and corresponding examples in the right column. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples in the Local anesthetics class include bupivacaine among others.*

FDA Label Image

Rfid Labeling (Rfid U)

A printed label fragment showing a GS1 DataMatrix barcode and numeric identifiers including a GTIN (00351662158135), batch or lot number, and expiration date (300101). Text states distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275 with instruction to see the manufacturer's package insert. 'RX ONLY' is also printed vertically on the right.*

FDA Label Image

Structure (Structure)

Chemical structure of BUPIVACAINE HCI showing the molecular composition with a piperidine ring, amide bond, aromatic ring with methyl groups, and associated hydrochloride and water molecules.*

FDA Label Image

Vial (Vial)

Label for Bupivacaine HCl Injection USP 0.25% (2.5 mg/mL) in a 50 mL multiple dose vial. The label indicates it contains 125 mg per 50 mL and is intended for infiltration and nerve block. It is distributed by AuroMedics Pharma LLC and includes storage instructions and ingredient details. The label carries a barcode and QR code.*

FDA Label Image

Warnings (Warning)

Text panel warning about the 0.75% concentration of bupivacaine hydrochloride, advising against its use for obstetrical anesthesia due to risks of cardiac arrest and difficulty in resuscitation. It notes that this concentration is recommended only for surgical procedures needing high muscle relaxation and prolonged effect.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.